COVID-19 Impact on Global Antidepressants Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 97 pages | ID: C29C84EDF14EEN
QYResearch

Abstracts

This report focuses on the global Antidepressants Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antidepressants Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Pfizer
• AstraZeneca
• Eli Lilly and Company
• Novartis
• GlaxoSmithKline
• Otsuka Pharmaceutical
• Abbott Laboratories
• Gedeon Richter
• Janssen Pharmaceuticals
• Lupin Pharmaceuticals
• Luye Pharma
• MSI Methylation Sciences
• Naurex
• SK Biopharmaceuticals

Market segment by Type, the product can be split into

• Tricyclic Antidepressants
• Serotonin-norepinephrine Inhibitors
• Atypical Antipsychotics
• Selective Serotonin Reuptake Inhibitors
• Benzodiazepines
• Tetracyclic Antidepressants
• Monoamine Oxidase Inhibitors
• Others

Market segment by Application, split into

• Hospitals
• Clinics
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Antidepressants Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Antidepressants Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Antidepressants Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Antidepressants Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Antidepressants Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Tricyclic Antidepressants
  1.4.3 Serotonin-norepinephrine Inhibitors
  1.4.4 Atypical Antipsychotics
  1.4.5 Selective Serotonin Reuptake Inhibitors
  1.4.6 Benzodiazepines
  1.4.7 Tetracyclic Antidepressants
  1.4.8 Monoamine Oxidase Inhibitors
  1.4.9 Others
1.5 Market by Application
  1.5.1 Global Antidepressants Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinics
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Antidepressants Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Antidepressants Drugs Industry
    1.6.1.1 Antidepressants Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Antidepressants Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Antidepressants Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Antidepressants Drugs Market Perspective (2015-2026)
2.2 Antidepressants Drugs Growth Trends by Regions
  2.2.1 Antidepressants Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Antidepressants Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Antidepressants Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Antidepressants Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Antidepressants Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Antidepressants Drugs Players by Market Size
  3.1.1 Global Top Antidepressants Drugs Players by Revenue (2015-2020)
  3.1.2 Global Antidepressants Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Antidepressants Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Antidepressants Drugs Market Concentration Ratio
  3.2.1 Global Antidepressants Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Antidepressants Drugs Revenue in 2019
3.3 Antidepressants Drugs Key Players Head office and Area Served
3.4 Key Players Antidepressants Drugs Product Solution and Service
3.5 Date of Enter into Antidepressants Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Antidepressants Drugs Historic Market Size by Type (2015-2020)
4.2 Global Antidepressants Drugs Forecasted Market Size by Type (2021-2026)

5 ANTIDEPRESSANTS DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Antidepressants Drugs Market Size by Application (2015-2020)
5.2 Global Antidepressants Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Antidepressants Drugs Market Size (2015-2020)
6.2 Antidepressants Drugs Key Players in North America (2019-2020)
6.3 North America Antidepressants Drugs Market Size by Type (2015-2020)
6.4 North America Antidepressants Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Antidepressants Drugs Market Size (2015-2020)
7.2 Antidepressants Drugs Key Players in Europe (2019-2020)
7.3 Europe Antidepressants Drugs Market Size by Type (2015-2020)
7.4 Europe Antidepressants Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Antidepressants Drugs Market Size (2015-2020)
8.2 Antidepressants Drugs Key Players in China (2019-2020)
8.3 China Antidepressants Drugs Market Size by Type (2015-2020)
8.4 China Antidepressants Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Antidepressants Drugs Market Size (2015-2020)
9.2 Antidepressants Drugs Key Players in Japan (2019-2020)
9.3 Japan Antidepressants Drugs Market Size by Type (2015-2020)
9.4 Japan Antidepressants Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Antidepressants Drugs Market Size (2015-2020)
10.2 Antidepressants Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Antidepressants Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Antidepressants Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Antidepressants Drugs Market Size (2015-2020)
11.2 Antidepressants Drugs Key Players in India (2019-2020)
11.3 India Antidepressants Drugs Market Size by Type (2015-2020)
11.4 India Antidepressants Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Antidepressants Drugs Market Size (2015-2020)
12.2 Antidepressants Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Antidepressants Drugs Market Size by Type (2015-2020)
12.4 Central & South America Antidepressants Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Antidepressants Drugs Introduction
  13.1.4 Pfizer Revenue in Antidepressants Drugs Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 AstraZeneca
  13.2.1 AstraZeneca Company Details
  13.2.2 AstraZeneca Business Overview and Its Total Revenue
  13.2.3 AstraZeneca Antidepressants Drugs Introduction
  13.2.4 AstraZeneca Revenue in Antidepressants Drugs Business (2015-2020)
  13.2.5 AstraZeneca Recent Development
13.3 Eli Lilly and Company
  13.3.1 Eli Lilly and Company Company Details
  13.3.2 Eli Lilly and Company Business Overview and Its Total Revenue
  13.3.3 Eli Lilly and Company Antidepressants Drugs Introduction
  13.3.4 Eli Lilly and Company Revenue in Antidepressants Drugs Business (2015-2020)
  13.3.5 Eli Lilly and Company Recent Development
13.4 Novartis
  13.4.1 Novartis Company Details
  13.4.2 Novartis Business Overview and Its Total Revenue
  13.4.3 Novartis Antidepressants Drugs Introduction
  13.4.4 Novartis Revenue in Antidepressants Drugs Business (2015-2020)
  13.4.5 Novartis Recent Development
13.5 GlaxoSmithKline
  13.5.1 GlaxoSmithKline Company Details
  13.5.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.5.3 GlaxoSmithKline Antidepressants Drugs Introduction
  13.5.4 GlaxoSmithKline Revenue in Antidepressants Drugs Business (2015-2020)
  13.5.5 GlaxoSmithKline Recent Development
13.6 Otsuka Pharmaceutical
  13.6.1 Otsuka Pharmaceutical Company Details
  13.6.2 Otsuka Pharmaceutical Business Overview and Its Total Revenue
  13.6.3 Otsuka Pharmaceutical Antidepressants Drugs Introduction
  13.6.4 Otsuka Pharmaceutical Revenue in Antidepressants Drugs Business (2015-2020)
  13.6.5 Otsuka Pharmaceutical Recent Development
13.7 Abbott Laboratories
  13.7.1 Abbott Laboratories Company Details
  13.7.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.7.3 Abbott Laboratories Antidepressants Drugs Introduction
  13.7.4 Abbott Laboratories Revenue in Antidepressants Drugs Business (2015-2020)
  13.7.5 Abbott Laboratories Recent Development
13.8 Gedeon Richter
  13.8.1 Gedeon Richter Company Details
  13.8.2 Gedeon Richter Business Overview and Its Total Revenue
  13.8.3 Gedeon Richter Antidepressants Drugs Introduction
  13.8.4 Gedeon Richter Revenue in Antidepressants Drugs Business (2015-2020)
  13.8.5 Gedeon Richter Recent Development
13.9 Janssen Pharmaceuticals
  13.9.1 Janssen Pharmaceuticals Company Details
  13.9.2 Janssen Pharmaceuticals Business Overview and Its Total Revenue
  13.9.3 Janssen Pharmaceuticals Antidepressants Drugs Introduction
  13.9.4 Janssen Pharmaceuticals Revenue in Antidepressants Drugs Business (2015-2020)
  13.9.5 Janssen Pharmaceuticals Recent Development
13.10 Lupin Pharmaceuticals
  13.10.1 Lupin Pharmaceuticals Company Details
  13.10.2 Lupin Pharmaceuticals Business Overview and Its Total Revenue
  13.10.3 Lupin Pharmaceuticals Antidepressants Drugs Introduction
  13.10.4 Lupin Pharmaceuticals Revenue in Antidepressants Drugs Business (2015-2020)
  13.10.5 Lupin Pharmaceuticals Recent Development
13.11 Luye Pharma
  10.11.1 Luye Pharma Company Details
  10.11.2 Luye Pharma Business Overview and Its Total Revenue
  10.11.3 Luye Pharma Antidepressants Drugs Introduction
  10.11.4 Luye Pharma Revenue in Antidepressants Drugs Business (2015-2020)
  10.11.5 Luye Pharma Recent Development
13.12 MSI Methylation Sciences
  10.12.1 MSI Methylation Sciences Company Details
  10.12.2 MSI Methylation Sciences Business Overview and Its Total Revenue
  10.12.3 MSI Methylation Sciences Antidepressants Drugs Introduction
  10.12.4 MSI Methylation Sciences Revenue in Antidepressants Drugs Business (2015-2020)
  10.12.5 MSI Methylation Sciences Recent Development
13.13 Naurex
  10.13.1 Naurex Company Details
  10.13.2 Naurex Business Overview and Its Total Revenue
  10.13.3 Naurex Antidepressants Drugs Introduction
  10.13.4 Naurex Revenue in Antidepressants Drugs Business (2015-2020)
  10.13.5 Naurex Recent Development
13.14 SK Biopharmaceuticals
  10.14.1 SK Biopharmaceuticals Company Details
  10.14.2 SK Biopharmaceuticals Business Overview and Its Total Revenue
  10.14.3 SK Biopharmaceuticals Antidepressants Drugs Introduction
  10.14.4 SK Biopharmaceuticals Revenue in Antidepressants Drugs Business (2015-2020)
  10.14.5 SK Biopharmaceuticals Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Antidepressants Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Antidepressants Drugs Revenue
Table 3. Ranking of Global Top Antidepressants Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Antidepressants Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Tricyclic Antidepressants
Table 6. Key Players of Serotonin-norepinephrine Inhibitors
Table 7. Key Players of Atypical Antipsychotics
Table 8. Key Players of Selective Serotonin Reuptake Inhibitors
Table 9. Key Players of Benzodiazepines
Table 10. Key Players of Tetracyclic Antidepressants
Table 11. Key Players of Monoamine Oxidase Inhibitors
Table 12. Key Players of Others
Table 13. COVID-19 Impact Global Market: (Four Antidepressants Drugs Market Size Forecast Scenarios)
Table 14. Opportunities and Trends for Antidepressants Drugs Players in the COVID-19 Landscape
Table 15. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 16. Key Regions/Countries Measures against Covid-19 Impact
Table 17. Proposal for Antidepressants Drugs Players to Combat Covid-19 Impact
Table 18. Global Antidepressants Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 19. Global Antidepressants Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 20. Global Antidepressants Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 21. Global Antidepressants Drugs Market Share by Regions (2015-2020)
Table 22. Global Antidepressants Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 23. Global Antidepressants Drugs Market Share by Regions (2021-2026)
Table 24. Market Top Trends
Table 25. Key Drivers: Impact Analysis
Table 26. Key Challenges
Table 27. Antidepressants Drugs Market Growth Strategy
Table 28. Main Points Interviewed from Key Antidepressants Drugs Players
Table 29. Global Antidepressants Drugs Revenue by Players (2015-2020) (Million US$)
Table 30. Global Antidepressants Drugs Market Share by Players (2015-2020)
Table 31. Global Top Antidepressants Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antidepressants Drugs as of 2019)
Table 32. Global Antidepressants Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 33. Key Players Headquarters and Area Served
Table 34. Key Players Antidepressants Drugs Product Solution and Service
Table 35. Date of Enter into Antidepressants Drugs Market
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Antidepressants Drugs Market Size by Type (2015-2020) (Million US$)
Table 38. Global Antidepressants Drugs Market Size Share by Type (2015-2020)
Table 39. Global Antidepressants Drugs Revenue Market Share by Type (2021-2026)
Table 40. Global Antidepressants Drugs Market Size Share by Application (2015-2020)
Table 41. Global Antidepressants Drugs Market Size by Application (2015-2020) (Million US$)
Table 42. Global Antidepressants Drugs Market Size Share by Application (2021-2026)
Table 43. North America Key Players Antidepressants Drugs Revenue (2019-2020) (Million US$)
Table 44. North America Key Players Antidepressants Drugs Market Share (2019-2020)
Table 45. North America Antidepressants Drugs Market Size by Type (2015-2020) (Million US$)
Table 46. North America Antidepressants Drugs Market Share by Type (2015-2020)
Table 47. North America Antidepressants Drugs Market Size by Application (2015-2020) (Million US$)
Table 48. North America Antidepressants Drugs Market Share by Application (2015-2020)
Table 49. Europe Key Players Antidepressants Drugs Revenue (2019-2020) (Million US$)
Table 50. Europe Key Players Antidepressants Drugs Market Share (2019-2020)
Table 51. Europe Antidepressants Drugs Market Size by Type (2015-2020) (Million US$)
Table 52. Europe Antidepressants Drugs Market Share by Type (2015-2020)
Table 53. Europe Antidepressants Drugs Market Size by Application (2015-2020) (Million US$)
Table 54. Europe Antidepressants Drugs Market Share by Application (2015-2020)
Table 55. China Key Players Antidepressants Drugs Revenue (2019-2020) (Million US$)
Table 56. China Key Players Antidepressants Drugs Market Share (2019-2020)
Table 57. China Antidepressants Drugs Market Size by Type (2015-2020) (Million US$)
Table 58. China Antidepressants Drugs Market Share by Type (2015-2020)
Table 59. China Antidepressants Drugs Market Size by Application (2015-2020) (Million US$)
Table 60. China Antidepressants Drugs Market Share by Application (2015-2020)
Table 61. Japan Key Players Antidepressants Drugs Revenue (2019-2020) (Million US$)
Table 62. Japan Key Players Antidepressants Drugs Market Share (2019-2020)
Table 63. Japan Antidepressants Drugs Market Size by Type (2015-2020) (Million US$)
Table 64. Japan Antidepressants Drugs Market Share by Type (2015-2020)
Table 65. Japan Antidepressants Drugs Market Size by Application (2015-2020) (Million US$)
Table 66. Japan Antidepressants Drugs Market Share by Application (2015-2020)
Table 67. Southeast Asia Key Players Antidepressants Drugs Revenue (2019-2020) (Million US$)
Table 68. Southeast Asia Key Players Antidepressants Drugs Market Share (2019-2020)
Table 69. Southeast Asia Antidepressants Drugs Market Size by Type (2015-2020) (Million US$)
Table 70. Southeast Asia Antidepressants Drugs Market Share by Type (2015-2020)
Table 71. Southeast Asia Antidepressants Drugs Market Size by Application (2015-2020) (Million US$)
Table 72. Southeast Asia Antidepressants Drugs Market Share by Application (2015-2020)
Table 73. India Key Players Antidepressants Drugs Revenue (2019-2020) (Million US$)
Table 74. India Key Players Antidepressants Drugs Market Share (2019-2020)
Table 75. India Antidepressants Drugs Market Size by Type (2015-2020) (Million US$)
Table 76. India Antidepressants Drugs Market Share by Type (2015-2020)
Table 77. India Antidepressants Drugs Market Size by Application (2015-2020) (Million US$)
Table 78. India Antidepressants Drugs Market Share by Application (2015-2020)
Table 79. Central & South America Key Players Antidepressants Drugs Revenue (2019-2020) (Million US$)
Table 80. Central & South America Key Players Antidepressants Drugs Market Share (2019-2020)
Table 81. Central & South America Antidepressants Drugs Market Size by Type (2015-2020) (Million US$)
Table 82. Central & South America Antidepressants Drugs Market Share by Type (2015-2020)
Table 83. Central & South America Antidepressants Drugs Market Size by Application (2015-2020) (Million US$)
Table 84. Central & South America Antidepressants Drugs Market Share by Application (2015-2020)
Table 85. Pfizer Company Details
Table 86. Pfizer Business Overview
Table 87. Pfizer Product
Table 88. Pfizer Revenue in Antidepressants Drugs Business (2015-2020) (Million US$)
Table 89. Pfizer Recent Development
Table 90. AstraZeneca Company Details
Table 91. AstraZeneca Business Overview
Table 92. AstraZeneca Product
Table 93. AstraZeneca Revenue in Antidepressants Drugs Business (2015-2020) (Million US$)
Table 94. AstraZeneca Recent Development
Table 95. Eli Lilly and Company Company Details
Table 96. Eli Lilly and Company Business Overview
Table 97. Eli Lilly and Company Product
Table 98. Eli Lilly and Company Revenue in Antidepressants Drugs Business (2015-2020) (Million US$)
Table 99. Eli Lilly and Company Recent Development
Table 100. Novartis Company Details
Table 101. Novartis Business Overview
Table 102. Novartis Product
Table 103. Novartis Revenue in Antidepressants Drugs Business (2015-2020) (Million US$)
Table 104. Novartis Recent Development
Table 105. GlaxoSmithKline Company Details
Table 106. GlaxoSmithKline Business Overview
Table 107. GlaxoSmithKline Product
Table 108. GlaxoSmithKline Revenue in Antidepressants Drugs Business (2015-2020) (Million US$)
Table 109. GlaxoSmithKline Recent Development
Table 110. Otsuka Pharmaceutical Company Details
Table 111. Otsuka Pharmaceutical Business Overview
Table 112. Otsuka Pharmaceutical Product
Table 113. Otsuka Pharmaceutical Revenue in Antidepressants Drugs Business (2015-2020) (Million US$)
Table 114. Otsuka Pharmaceutical Recent Development
Table 115. Abbott Laboratories Company Details
Table 116. Abbott Laboratories Business Overview
Table 117. Abbott Laboratories Product
Table 118. Abbott Laboratories Revenue in Antidepressants Drugs Business (2015-2020) (Million US$)
Table 119. Abbott Laboratories Recent Development
Table 120. Gedeon Richter Business Overview
Table 121. Gedeon Richter Product
Table 122. Gedeon Richter Company Details
Table 123. Gedeon Richter Revenue in Antidepressants Drugs Business (2015-2020) (Million US$)
Table 124. Gedeon Richter Recent Development
Table 125. Janssen Pharmaceuticals Company Details
Table 126. Janssen Pharmaceuticals Business Overview
Table 127. Janssen Pharmaceuticals Product
Table 128. Janssen Pharmaceuticals Revenue in Antidepressants Drugs Business (2015-2020) (Million US$)
Table 129. Janssen Pharmaceuticals Recent Development
Table 130. Lupin Pharmaceuticals Company Details
Table 131. Lupin Pharmaceuticals Business Overview
Table 132. Lupin Pharmaceuticals Product
Table 133. Lupin Pharmaceuticals Revenue in Antidepressants Drugs Business (2015-2020) (Million US$)
Table 134. Lupin Pharmaceuticals Recent Development
Table 135. Luye Pharma Company Details
Table 136. Luye Pharma Business Overview
Table 137. Luye Pharma Product
Table 138. Luye Pharma Revenue in Antidepressants Drugs Business (2015-2020) (Million US$)
Table 139. Luye Pharma Recent Development
Table 140. MSI Methylation Sciences Company Details
Table 141. MSI Methylation Sciences Business Overview
Table 142. MSI Methylation Sciences Product
Table 143. MSI Methylation Sciences Revenue in Antidepressants Drugs Business (2015-2020) (Million US$)
Table 144. MSI Methylation Sciences Recent Development
Table 145. Naurex Company Details
Table 146. Naurex Business Overview
Table 147. Naurex Product
Table 148. Naurex Revenue in Antidepressants Drugs Business (2015-2020) (Million US$)
Table 149. Naurex Recent Development
Table 150. SK Biopharmaceuticals Company Details
Table 151. SK Biopharmaceuticals Business Overview
Table 152. SK Biopharmaceuticals Product
Table 153. SK Biopharmaceuticals Revenue in Antidepressants Drugs Business (2015-2020) (Million US$)
Table 154. SK Biopharmaceuticals Recent Development
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Antidepressants Drugs Market Share by Type: 2020 VS 2026
Figure 2. Tricyclic Antidepressants Features
Figure 3. Serotonin-norepinephrine Inhibitors Features
Figure 4. Atypical Antipsychotics Features
Figure 5. Selective Serotonin Reuptake Inhibitors Features
Figure 6. Benzodiazepines Features
Figure 7. Tetracyclic Antidepressants Features
Figure 8. Monoamine Oxidase Inhibitors Features
Figure 9. Others Features
Figure 10. Global Antidepressants Drugs Market Share by Application: 2020 VS 2026
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Others Case Studies
Figure 14. Antidepressants Drugs Report Years Considered
Figure 15. Global Antidepressants Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Antidepressants Drugs Market Share by Regions: 2020 VS 2026
Figure 17. Global Antidepressants Drugs Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Antidepressants Drugs Market Share by Players in 2019
Figure 20. Global Top Antidepressants Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antidepressants Drugs as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Antidepressants Drugs Revenue in 2019
Figure 22. North America Antidepressants Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Antidepressants Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Antidepressants Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Antidepressants Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Antidepressants Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Antidepressants Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Antidepressants Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Pfizer Revenue Growth Rate in Antidepressants Drugs Business (2015-2020)
Figure 31. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. AstraZeneca Revenue Growth Rate in Antidepressants Drugs Business (2015-2020)
Figure 33. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Eli Lilly and Company Revenue Growth Rate in Antidepressants Drugs Business (2015-2020)
Figure 35. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Novartis Revenue Growth Rate in Antidepressants Drugs Business (2015-2020)
Figure 37. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. GlaxoSmithKline Revenue Growth Rate in Antidepressants Drugs Business (2015-2020)
Figure 39. Otsuka Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Otsuka Pharmaceutical Revenue Growth Rate in Antidepressants Drugs Business (2015-2020)
Figure 41. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Abbott Laboratories Revenue Growth Rate in Antidepressants Drugs Business (2015-2020)
Figure 43. Gedeon Richter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Gedeon Richter Revenue Growth Rate in Antidepressants Drugs Business (2015-2020)
Figure 45. Janssen Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Janssen Pharmaceuticals Revenue Growth Rate in Antidepressants Drugs Business (2015-2020)
Figure 47. Lupin Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Lupin Pharmaceuticals Revenue Growth Rate in Antidepressants Drugs Business (2015-2020)
Figure 49. Luye Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Luye Pharma Revenue Growth Rate in Antidepressants Drugs Business (2015-2020)
Figure 51. MSI Methylation Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. MSI Methylation Sciences Revenue Growth Rate in Antidepressants Drugs Business (2015-2020)
Figure 53. Naurex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Naurex Revenue Growth Rate in Antidepressants Drugs Business (2015-2020)
Figure 55. SK Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. SK Biopharmaceuticals Revenue Growth Rate in Antidepressants Drugs Business (2015-2020)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed